Pharmaceutical News

RSS

Inovio Biomedical announces positive test results of its consensus influenza vaccines

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and strains in ferrets.

20 Nov 2009

BioForm Medical and Galderma Laboratories Chiefs to offer their perspectives on aesthetics market at ODAC conference

The Orlando Dermatology Aesthetic & Clinical (ODAC) conference is proud to welcome two leading executive officers offering their unique perspectives on the state of the industry and future opportunities at its 7th annual program, being held on January 15, 2010 at The Peabody Orlando in Orlando, Florida.

20 Nov 2009

Only 1 in 4 Americans aged 50-64 regularly take advantage of preventive screenings, says report

Only about 1 in 4 Americans aged 50-64 regularly take advantage of preventive services such as screenings and immunizations, according to a report from the Centers for Disease Control and Prevention in collaboration with AARP and the American Medical Association (AMA).

20 Nov 2009

Study examines temporal association between media coverage and opioid-related deaths

Increases in deaths from opioid drugs such as OxyContin may be linked to the volume of coverage such deaths receive in the news, according to a study from Children's Hospital Boston and the University of North Carolina (UNC), Chapel Hill. The study compared patterns of opioid deaths and patterns of news coverage between 1999 and 2005, during which time mortality rates from opioid abuse doubled.

20 Nov 2009

LAIV and TIV vaccines appear to offer protection against A/H1N1 virus

Immunization with either live attenuated influenza vaccine (LAIV, also known as FluMist®), or trivalent inactivated influenza vaccine (TIV), appears to offer a protection (~ 45%) against the novel A/H1N1 virus, the cause of the present influenza pandemic. However, the benefit was largely attributed to the youngest age group. The finding emerges from an evaluation of medical encounters and seasonal influenza immunization of U.S. military service members.

20 Nov 2009

Deloitte Consulting offers new sales strategy for pharmaceutical companies

Pharmaceutical companies face a fundamental decision about the best way to sell their products. Even if they could find a way to make the current sales model work, pharma companies still face sky-high commercial costs. So, the question is, should pharma companies stick with their traditional sales approach or blow it up and try something new?

20 Nov 2009

Global initiative battles online supply of dangerous and illegal medicines

In response to an ever-increasing number of websites supplying dangerous and illegal medicines, Operation Pangea II, involving 24 countries, was coordinated by INTERPOL and the World Health Organization's International Medical Products Anti-Counterfeiting Taskforce (IMPACT) to highlight the dangers of buying medicines online.

20 Nov 2009

Significant increases in IT use have not reduced drug review process

Drug approvals are taking just as long as they ever did despite increased expenditure on new information technology at the Food and drug Administration. So says a statistical analysis of approval intervals from 1997 to 2006, published in the International Journal of Electronic Healthcare.

20 Nov 2009

Health care reform will not impact America's pharmaceutical research industry

A recent Reuters article reported that America's pharmaceutical research and biotechnology companies don't expect an industry increase as a result of broader insurance coverage proposed in health care reform.

20 Nov 2009

Discoveries on anti-HIV antibodies may help researchers create an effective HIV vaccine

New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

20 Nov 2009

Elsevier journal Vaccine releases a supplement dedicated to vaccines for biodefense

Last week during the 'Vaccines for Biothreats and Emerging and Neglected Diseases Symposium' in Galveston TX, USA, the Elsevier journal Vaccine released a supplement dedicated to vaccines for biodefense (www.sciencedirect.com/science/journal/0264410X).

20 Nov 2009

Purchasing prescription drugs in a three-month supply reduce cost of drugs for patients

Purchasing prescription drugs in a three-month supply rather than a one-month supply has long been regarded as a way to reduce the cost of drugs for patients and third-party payers. New research from the University of Chicago quantifies the savings for the first time.

20 Nov 2009

Scientists find how 4-HB is metabolized by the body

It's a naturally occurring brain chemical with an unwieldy name: 4-hydroxybutyrate (4-HB). Taken by mouth, it can be abused or used as a date-rape drug.

20 Nov 2009

ScinoPharm receives Potent Compound Safety Certification from SafeBridge Consultants

ScinoPharm, a leading global supplier of active pharmaceutical ingredients (APIs), announced that its Tainan facility has received the Potent Compound Safety Certification from SafeBridge(R) Consultants, Inc.

20 Nov 2009

Swissmedic grants marketing authorization for Amitiza

Sucampo Pharma Europe Ltd., a subsidiary of Sucampo Pharmaceuticals, Inc., today announced that Swissmedic, the Swiss Agency for Therapeutic Products, has granted a marketing authorization for Amitiza® (lubiprostone) 24 microgram (mcg) gel capsules for the long-term treatment of patients with chronic idiopathic constipation (CIC).

20 Nov 2009

Experimental drug to restore function of nerves damaged in spinal cord injuries shows promise

Researchers have shown how an experimental drug might restore the function of nerves damaged in spinal cord injuries by preventing short circuits caused when tiny "potassium channels" in the fibers are exposed.

20 Nov 2009

CDAS, Prestwick Chemical sign drug discovery research agreement

Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, today announced a strategic partnership between the company's contract research organization, Caliper Discovery Alliances & Services (CDAS), and Prestwick Chemical (Strasbourg, France) to provide customized outsourced medicinal chemistry and in vitro and in vivo preclinical biology programs for drug discovery research.

19 Nov 2009

Ligon Discovery raises $1 million

Ligon Discovery, Inc., which uses proprietary small molecule microarray technology to find drugs against high-value targets, today announced that it has raised $1M in seed financing led by incTANK Ventures. The company will use the capital to complete its initial discovery campaign that will screen over 100 high-value disease protein targets. With this investment, incTANK Ventures General Partner Christian Bailey joins the board.

19 Nov 2009

Pfizer,DNDi partner to Identify NTD drugs; Sanofi-Aventis, medicines for malaria launch drug study

Pfizer and the Drugs for Neglected Diseases Initiative (DNDi) on Wednesday announced plans to team up in an effort to identify new drug candidates for the treatment of three tropical diseases, the Associated Press/Business Week reports. The scientists will test the efficacy of Pfizer drug candidates against sleeping sickness, visceral leishmaniasis, and Chagas disease.

19 Nov 2009

Op-Eds: HIV travel ban; improving sanitation; counterfeit drugs

A "blot" on U.S. HIV/AIDS leadership "ended last month when President [Barack] Obama lifted the prohibition" that kept HIV-positive foreigners from visiting the U.S. or seeking residency, according to a Washington Post editorial. "The process for eliminating the travel ban started under President George W. Bush in July 2008, when he signed legislation that repealed the original statute."

19 Nov 2009

Pharmaceutical News

Inovio Biomedical announces positive test results of its consensus influenza vaccines

BioForm Medical and Galderma Laboratories Chiefs to offer their perspectives on aesthetics market at ODAC conference

Only 1 in 4 Americans aged 50-64 regularly take advantage of preventive screenings, says report

Study examines temporal association between media coverage and opioid-related deaths

LAIV and TIV vaccines appear to offer protection against A/H1N1 virus

Deloitte Consulting offers new sales strategy for pharmaceutical companies

Global initiative battles online supply of dangerous and illegal medicines

Significant increases in IT use have not reduced drug review process

Health care reform will not impact America's pharmaceutical research industry

Discoveries on anti-HIV antibodies may help researchers create an effective HIV vaccine

Elsevier journal Vaccine releases a supplement dedicated to vaccines for biodefense

Purchasing prescription drugs in a three-month supply reduce cost of drugs for patients

Scientists find how 4-HB is metabolized by the body

ScinoPharm receives Potent Compound Safety Certification from SafeBridge Consultants

Swissmedic grants marketing authorization for Amitiza

Experimental drug to restore function of nerves damaged in spinal cord injuries shows promise

CDAS, Prestwick Chemical sign drug discovery research agreement

Ligon Discovery raises $1 million

Pfizer,DNDi partner to Identify NTD drugs; Sanofi-Aventis, medicines for malaria launch drug study

Op-Eds: HIV travel ban; improving sanitation; counterfeit drugs

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News